Imagin Medical Inc C.IME

Alternate Symbol(s): IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.

CSE:IME - Post by User

Imagin Medical Inc

Bullboard Posts

Comment by mercury191on Sep 26, 2019 2:58pm

237 Views

Post# 30167538

RE:NEWS

Good confirmation here. Everything is on track.

Verification of product and documentation in Q4 means production Q1 and final validation testing immediately after.

They met with FDA in September and confirmed they are going for the shorter "safe and effective" path. That is significant and means they won't need overly involved clinical trials to be approved for marketing.

Timiline to market just got shorter by 6 months IMO. Great news.

Expect buyout before this goes to market.

Cheers.
Merc